169 related articles for article (PubMed ID: 10858366)
1. Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas.
Bebear CM; Renaudin H; Bryskier A; Bebear C
Antimicrob Agents Chemother; 2000 Jul; 44(7):1980-2. PubMed ID: 10858366
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against gram-positive clinical isolates in Japan.
Okamoto H; Miyazaki S; Tateda K; Ishii Y; Yamaguchi K
J Antimicrob Chemother; 2000 Nov; 46(5):797-802. PubMed ID: 11062201
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of ketolides HMR 3647 [correction of HRM 3647] and HMR 3004 [correction of HRM 3004], levofloxacin, and other quinolones and macrolides against Neisseria spp. and Moraxella catarrhalis.
Sáez-Nieto JA; Vázquez JA
Antimicrob Agents Chemother; 1999 Apr; 43(4):983-4. PubMed ID: 10103218
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the in vitro efficacy of telithromycin (HMR 3647) and levofloxacin with 22 antibiotic compounds against Bosea and Afipia species.
La Scola B; Bryskier A; Raoult D
J Antimicrob Chemother; 2004 Apr; 53(4):683-5. PubMed ID: 14998981
[No Abstract] [Full Text] [Related]
5. Comparative in vitro activity of penicillin G, levofloxacin, moxifloxacin, telithromycin, pristinamycin, quinupristin-dalfopristin and linezolid against ofloxacin-intermediate and -resistant Streptococcus pneumoniae.
Frédénucci I; Chomarat M; Bercion R; Carricajo A; Celard M; Croizé J; Delubac F; Fèvre D; Fuhrmann C; Helfre M; Letouzey MN; Lelièvre H; Mandjee A; Marthelet P; Meley R; Perrier-Gros-Claude JD; Ros A; Roure C; Smati S; Thierry J; Tous J
Clin Microbiol Infect; 2002 Oct; 8(10):680-3. PubMed ID: 12390289
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101.
Waites KB; Crabb DM; Duffy LB
Antimicrob Agents Chemother; 2009 May; 53(5):2139-41. PubMed ID: 19258276
[TBL] [Abstract][Full Text] [Related]
7. Comparative in-vitro activity of levofloxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis.
Ullmann U; Schubert S; Krausse R
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():33-6. PubMed ID: 10404335
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodology.
Kays MB; Lisek CR; Denys GA
Int J Antimicrob Agents; 2007 Mar; 29(3):289-94. PubMed ID: 17240118
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of ketolides HMR 3004 and HMR 3647 and seven other antimicrobial agents against Corynebacterium diphtheriae.
Engler KH; Warner M; George RC
J Antimicrob Chemother; 2001 Jan; 47(1):27-31. PubMed ID: 11152428
[TBL] [Abstract][Full Text] [Related]
10. Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pneumococci from 10 central and Eastern European countries.
Nagai K; Appelbaum PC; Davies TA; Kelly LM; Hoellman DB; Andrasevic AT; Drukalska L; Hryniewicz W; Jacobs MR; Kolman J; Miciuleviciene J; Pana M; Setchanova L; Thege MK; Hupkova H; Trupl J; Urbaskova P
Antimicrob Agents Chemother; 2002 Feb; 46(2):371-7. PubMed ID: 11796344
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of Mycoplasma hominis clinical isolates to tetracyclines, quinolones and macrolides.
Samra Z; Rosenberg S; Soffer Y
Diagn Microbiol Infect Dis; 2002 Dec; 44(4):359-61. PubMed ID: 12543541
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila.
Baltch AL; Smith RP; Ritz WJ; Franke MA; Michelsen PB
J Antimicrob Chemother; 2000 Jul; 46(1):51-5. PubMed ID: 10882688
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of telithromycin (HMR3647), a new ketolide, against clinical isolates of Mycoplasma pneumoniae in Japan.
Yamaguchi T; Hirakata Y; Izumikawa K; Miyazaki Y; Maesaki S; Tomono K; Yamada Y; Kamihira S; Kohno S
Antimicrob Agents Chemother; 2000 May; 44(5):1381-2. PubMed ID: 10770785
[TBL] [Abstract][Full Text] [Related]
14. Activities of antimicrobial agents against intracellular pneumococci.
Mandell GL; Coleman EJ
Antimicrob Agents Chemother; 2000 Sep; 44(9):2561-3. PubMed ID: 10952618
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe.
Critchley IA; Jones ME; Heinze PD; Hubbard D; Engler HD; Evangelista AT; Thornsberry C; Karlowsky JA; Sahm DF
Clin Microbiol Infect; 2002 Apr; 8(4):214-21. PubMed ID: 12047413
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of several antimicrobial agents against genital mycoplasmas.
Echániz Avilés G; Conde González C; Juárez Figueroa L; Carnalla Barajas N; Tamayo Legorreta E; Calderón Jaimes E
Clin Ther; 1992; 14(5):688-95. PubMed ID: 1468088
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas.
Waites KB; Crabb DM; Duffy LB
Antimicrob Agents Chemother; 2003 Jan; 47(1):39-42. PubMed ID: 12499166
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.
Waites KB; Cassell GH; Canupp KC; Fernandes PB
Antimicrob Agents Chemother; 1988 Oct; 32(10):1500-2. PubMed ID: 2973283
[TBL] [Abstract][Full Text] [Related]
19. Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp.
Duffy LB; Crabb D; Searcey K; Kempf MC
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():29-33. PubMed ID: 10824029
[TBL] [Abstract][Full Text] [Related]
20. Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes.
Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K
Antimicrob Agents Chemother; 1999 Nov; 43(11):2801-5. PubMed ID: 10543769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
